CA19-9/Sialyl Lewis A Antibody (121SLE) - Azide and BSA Free, Novus Biologicals™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB254349100-Each-of-1 | In Stock | ₹ 55,271.76 |
NB254349100 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 55,271.76
GST (18%): ₹ 9,948.917
Total Price: ₹ 65,220.677
Antigen
CA19-9/Sialyl Lewisa
Classification
Monoclonal
Concentration
1 mg/mL
Dilution
Flow Cytometry 0.5 - 1 ug/million cells, Immunocytochemistry/Immunofluorescence 0.5 - 1 ug/ml, Immunohistochemistry-Paraffin 0.5 - 1.0 ug/ml
Host Species
Mouse
Molecular Weight of Antigen
400 kDa
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human
Form
Supernatant
Applications
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin)
Clone
121SLE
Conjugate
Unconjugated
Formulation
PBS with No Preservative
Immunogen
Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Purification Method
Tissue culture supernatant
Regulatory Status
RUO
Test Specificity
CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Content And Storage
Store at -20 to -80C. Avoid freeze-thaw cycles.
Isotype
IgM κ
Related Products
Description
- CA19-9/Sialyl Lewis A Monoclonal specifically detects CA19-9/Sialyl Lewis A in Human samples
- It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.
Compare Similar Items
Show Difference
Antigen: CA19-9/Sialyl Lewisa
Classification: Monoclonal
Concentration: 1 mg/mL
Dilution: Flow Cytometry 0.5 - 1 ug/million cells, Immunocytochemistry/Immunofluorescence 0.5 - 1 ug/ml, Immunohistochemistry-Paraffin 0.5 - 1.0 ug/ml
Host Species: Mouse
Molecular Weight of Antigen: 400 kDa
Quantity: 100 μg
Primary or Secondary: Primary
Target Species: Human
Form: Supernatant
Applications: Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin)
Clone: 121SLE
Conjugate: Unconjugated
Formulation: PBS with No Preservative
Immunogen: Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Purification Method: Tissue culture supernatant
Regulatory Status: RUO
Test Specificity: CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Content And Storage: Store at -20 to -80C. Avoid freeze-thaw cycles.
Isotype: IgM κ
Antigen: CA19-9/Sialyl Lewisa
Classification: Monoclonal
Concentration: 1 mg/mL
Dilution: Flow Cytometry 0.5 - 1 ug/million cells, Immunocytochemistry/Immunofluorescence 0.5 - 1 ug/ml, Immunohistochemistry-Paraffin 0.5 - 1.0 ug/ml
Host Species: Mouse
Molecular Weight of Antigen: 400 kDa
Quantity: 200 μg
Primary or Secondary: Primary
Target Species: Human
Form: Supernatant
Applications: Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin)
Clone: 121SLE
Conjugate: Unconjugated
Formulation: PBS with No Preservative
Immunogen: Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Purification Method: Tissue culture supernatant
Regulatory Status: RUO
Test Specificity: CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Content And Storage: Store at -20 to -80C. Avoid freeze-thaw cycles.
Isotype: IgM κ
Antigen: DDX43
Classification: Polyclonal
Concentration: __
Dilution: Western Blot
Host Species: Rabbit
Molecular Weight of Antigen: __
Quantity: 0.1 mL
Primary or Secondary: Primary
Target Species: Human
Form: Purified
Applications: Western Blot
Clone: __
Conjugate: DyLight 350
Formulation: 50mM Sodium Borate
Immunogen: The immunogen recognized by this antibody maps to a region between residue 275 and 325 of human DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 using the numbering given in entry NP_061135.1 (GeneID 55510).
Purification Method: Immunogen affinity purified
Regulatory Status: RUO
Test Specificity: __
Content And Storage: Store at 4°C in the dark.
Isotype: IgG
